Arbour Group

Arbour Group

Arbour Group operates as a specialized compliance and validation firm serving the life sciences industry, with operations spanning New York, Tokyo, and Oakbrook Terrace. For more than two decades, the firm has focused narrowly on helping pharmaceutical, biotech, and medical device companies satisfy regulatory requirements for electronic records and signatures — specifically FDA 21 CFR Part 11 and EU Annex 11 mandates. The firm's deployment model blends proprietary software products with hands-on managed services. Its validation product line supports software assurance and lean verification, commonly integrated into company-wide ERP rollouts. Service engagements cover quality assurance, software development compliance, and regulatory advisory for life sciences customers. The website points to integration work on multi-phase ERP implementations, suggesting a presence inside manufacturing and quality workflows at scale. Geographic delivery spans North America, Europe, and Asia via its three hubs. Team size, assets under management, and ownership structure are not disclosed publicly. The firm does not operate known philanthropic or adjacent investment vehicles. No dated operational events from the last 24 months could be confirmed from available sources. Arbour Group's structural differentiator is its product-plus-service bundling for a single regulated vertical. Rather than selling pure advisory hours, the firm licenses a validation product that clients embed into their compliance workflows, then layers managed services on top. This creates recurring revenue lines and a stickier relationship with audited life sciences operators than a traditional consulting-only engagement would produce.